ACN Newswire

Tue Oct 1

Eisai and Nichi-Iko Enter into Collaboration Agreement for Generic Pharmaceutical Business in China

Written by ACN Newswire

TOKYO, Sep 30, 2019 - (JCN Newswire) - Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.The Chinese pharmaceutical market is the second largest market in the world after the United States, and the generic drugs account for more than 70% of its...

ACN Newswire

Eisai and Nichi-Iko Enter into Collaboration Agreement for Generic Pharmaceutical Business in China

On the Battle of Seattle's 20th anniversary, let's remember the Aussie coders who created live sharing

Mind the gap – does age difference in relationships matter?

Shorten's subsidy plan to boost affordable housing

What happens to small towns whose water becomes big business for bottled brands?

Museum or not? The changing face of curated science, tech, art and culture

Dry lightning has set Tasmania ablaze, and climate change makes it more likely to happen again

What we learn from a fish that can change sex in just 10 days

Yang Hengjun's legal prospects in China appear grim, despite Australia's forceful defences

Bushfire education is too abstract. We need to get children into the real world

OM85: could bacteria in a capsule protect us from coronavirus and other respiratory infections?

From irreverence to irrelevance: the rise and fall of the bad-tempered tabloids